TBPH Insider Trading

Insider Ownership Percentage: 6.90%
Insider Buying (Last 12 Months): $7,798,440.00
Insider Selling (Last 12 Months): $108,000.00

Theravance Biopharma Insider Trading History Chart

This chart shows the insider buying and selling history at Theravance Biopharma by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Theravance Biopharma Share Price & Price History

Current Price: $9.21
Price Change: Price Decrease of -0.14 (-1.50%)
As of 03/18/2025 05:00 PM ET

This chart shows the closing price history over time for TBPH up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Theravance Biopharma Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
1/21/2025Rhonda FarnumSVPSell4,000$9.00$36,000.00309,565View SEC Filing Icon  
11/11/2024Rhonda FarnumSVPSell4,000$9.00$36,000.00322,743View SEC Filing Icon  
8/7/2024Eli SamahaMajor ShareholderBuy999,800$7.80$7,798,440.009,511,150View SEC Filing Icon  
7/10/2024Rhonda FarnumSVPSell4,000$9.00$36,000.00335,965View SEC Filing Icon  
2/22/2024Rhonda FarnumSVPSell1,254$8.71$10,922.34311,733View SEC Filing Icon  
11/21/2023Rhonda FarnumSVPSell1,378$10.29$14,179.62331,206View SEC Filing Icon  
11/14/2023Richard A GrahamSVPSell2,482$10.22$25,366.04346,839View SEC Filing Icon  
10/16/2023Richard A GrahamSVPSell2,482$9.03$22,412.46334,321View SEC Filing Icon  
9/14/2023Richard A GrahamSVPSell2,482$9.89$24,546.98336,803View SEC Filing Icon  
8/22/2023Rhonda FarnumSVPSell1,807$9.47$17,112.29340,566View SEC Filing Icon  
8/11/2023Richard A GrahamSVPSell2,322$9.99$23,196.78349,746View SEC Filing Icon  
7/14/2023Richard A GrahamSVPSell2,322$9.84$22,848.48352,068View SEC Filing Icon  
6/14/2023Richard A GrahamSVPSell2,322$10.69$24,822.18354,390View SEC Filing Icon  
6/8/2023Rhonda FarnumSVPSell1,790$11.13$19,922.70352,833View SEC Filing Icon  
5/15/2023Richard A GrahamSVPSell2,322$11.26$26,145.72367,172View SEC Filing Icon  
4/14/2023Richard A GrahamSVPSell2,323$11.88$27,597.24369,494View SEC Filing Icon  
3/14/2023Richard A GrahamSVPSell2,323$10.32$23,973.36371,817View SEC Filing Icon  
3/9/2023Rhonda FarnumSVPSell4,000$10.20$40,800.00360,190View SEC Filing Icon  
3/6/2023Richard A GrahamSVPSell2,323$10.05$23,346.15374,140View SEC Filing Icon  
12/14/2022Rick E WinninghamCEOSell50,000$11.19$559,500.001,350,797View SEC Filing Icon  
12/1/2022Richard A GrahamSVPSell2,084$10.73$22,361.32313,520View SEC Filing Icon  
8/16/2022Richard A GrahamSVPSell4,906$9.71$47,637.26364,745View SEC Filing Icon  
8/9/2022Richard A GrahamSVPSell15,086$8.79$132,605.94369,651View SEC Filing Icon  
5/23/2022Rhonda FarnumSVPSell1,081$8.93$9,653.33329,990View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Theravance Biopharma (NASDAQ:TBPH)

99.10% of Theravance Biopharma stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at TBPH by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Theravance Biopharma Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
2/19/2025Public Employees Retirement System of Ohio37,461$0.35M0.0%N/A0.076%Search for SEC Filing on Google Icon
2/17/2025UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC150,039$1.41M0.0%+27.7%0.305%Search for SEC Filing on Google Icon
2/17/2025Squarepoint Ops LLC47,168$0.44M0.0%-52.3%0.096%Search for SEC Filing on Google Icon
2/17/2025ProShare Advisors LLC12,672$0.12M0.0%N/A0.026%Search for SEC Filing on Google Icon
2/17/2025Man Group plc10,328$97K0.0%-59.0%0.021%Search for SEC Filing on Google Icon
2/17/2025Nuveen Asset Management LLC495,727$4.67M0.0%+10.9%1.008%Search for SEC Filing on Google Icon
2/17/2025Newtyn Management LLC4,757,403$44.77M7.8%+5.7%9.675%Search for SEC Filing on Google Icon
2/17/2025Millennium Management LLC192,839$1.82M0.0%+71.1%0.392%Search for SEC Filing on Google Icon
2/17/2025Jacobs Levy Equity Management Inc.438,463$4.13M0.0%-23.9%0.892%Search for SEC Filing on Google Icon
2/17/2025Graham Capital Management L.P.36,364$0.34M0.0%+18.2%0.074%Search for SEC Filing on Google Icon
2/17/2025Deutsche Bank AG46,550$0.44M0.0%+50.4%0.095%Search for SEC Filing on Google Icon
2/17/2025D. E. Shaw & Co. Inc.833,943$7.85M0.0%+9.0%1.696%Search for SEC Filing on Google Icon
2/17/2025Corton Capital Inc.33,346$0.31M0.2%N/A0.068%Search for SEC Filing on Google Icon
2/17/2025Bank of America Corp DE481,475$4.53M0.0%+2.7%0.979%Search for SEC Filing on Google Icon
2/17/2025Ameriprise Financial Inc.100,807$0.95M0.0%-9.7%0.205%Search for SEC Filing on Google Icon
2/14/2025Jane Street Group LLC52,344$0.49M0.0%-63.8%0.106%Search for SEC Filing on Google Icon
2/14/2025PDT Partners LLC37,676$0.36M0.0%-56.8%0.077%Search for SEC Filing on Google Icon
2/14/2025Park West Asset Management LLC1,792,988$16.87M1.4%-3.8%3.646%Search for SEC Filing on Google Icon
2/14/2025Northern Trust Corp389,980$3.67M0.0%+1.6%0.793%Search for SEC Filing on Google Icon
2/14/2025Aquatic Capital Management LLC2,604$25K0.0%N/A0.005%Search for SEC Filing on Google Icon
2/14/2025Virtus ETF Advisers LLC35,426$0.33M0.1%-7.7%0.072%Search for SEC Filing on Google Icon
2/14/2025Price T Rowe Associates Inc. MD64,795$0.61M0.0%+16.8%0.132%Search for SEC Filing on Google Icon
2/14/2025ClearAlpha Technologies LP11,586$0.11M0.1%N/A0.024%Search for SEC Filing on Google Icon
2/14/2025Tower Research Capital LLC TRC 12,670$0.12M0.0%+142.8%0.026%Search for SEC Filing on Google Icon
2/14/2025Dimensional Fund Advisors LP553,713$5.21M0.0%+20.8%1.126%Search for SEC Filing on Google Icon
2/13/2025Marshall Wace LLP66,067$0.62M0.0%-56.0%0.134%Search for SEC Filing on Google Icon
2/13/2025XTX Topco Ltd16,356$0.15M0.0%-20.0%0.033%Search for SEC Filing on Google Icon
2/13/2025Barclays PLC74,790$0.70M0.0%+14.0%0.152%Search for SEC Filing on Google Icon
2/13/2025Townsquare Capital LLC14,470$0.14M0.0%N/A0.029%Search for SEC Filing on Google Icon
2/13/2025Martingale Asset Management L P58,650$0.55M0.0%+7.7%0.119%Search for SEC Filing on Google Icon
2/13/2025Legal & General Group Plc41,218$0.39M0.0%-34.8%0.084%Search for SEC Filing on Google Icon
2/13/2025Invesco Ltd.46,050$0.43M0.0%+3.5%0.094%Search for SEC Filing on Google Icon
2/13/2025Russell Investments Group Ltd.21,990$0.21M0.0%-53.3%0.045%Search for SEC Filing on Google Icon
2/13/2025Wells Fargo & Company MN21,704$0.20M0.0%+27.6%0.044%Search for SEC Filing on Google Icon
2/12/2025Trexquant Investment LP151,083$1.42M0.0%+50.7%0.307%Search for SEC Filing on Google Icon
2/12/2025Geode Capital Management LLC862,802$8.12M0.0%+0.6%1.755%Search for SEC Filing on Google Icon
2/12/2025Alliancebernstein L.P.77,155$0.73M0.0%-2.2%0.157%Search for SEC Filing on Google Icon
2/12/2025Wellington Management Group LLP198,491$1.87M0.0%+3.7%0.404%Search for SEC Filing on Google Icon
2/12/2025JPMorgan Chase & Co.219,568$2.07M0.0%-17.7%0.447%Search for SEC Filing on Google Icon
2/11/2025Corebridge Financial Inc.18,258$0.17M0.0%-7.0%0.037%Search for SEC Filing on Google Icon
2/11/2025Vanguard Group Inc.2,010,544$18.92M0.0%-2.0%4.089%Search for SEC Filing on Google Icon
2/11/2025KLP Kapitalforvaltning AS7,300$69K0.0%N/A0.015%Search for SEC Filing on Google Icon
2/11/2025American Century Companies Inc.77,931$0.73M0.0%+11.9%0.158%Search for SEC Filing on Google Icon
2/11/2025Magnetar Financial LLC27,511$0.26M0.0%+125.8%0.056%Search for SEC Filing on Google Icon
2/11/2025Teacher Retirement System of Texas10,937$0.10M0.0%N/A0.022%Search for SEC Filing on Google Icon
2/6/2025Charles Schwab Investment Management Inc.293,936$2.77M0.0%+0.7%0.598%Search for SEC Filing on Google Icon
2/4/2025Bank of New York Mellon Corp115,779$1.09M0.0%-4.4%0.235%Search for SEC Filing on Google Icon
1/30/2025Rhumbline Advisers59,961$0.56M0.0%-4.9%0.122%Search for SEC Filing on Google Icon
1/17/2025SG Americas Securities LLC19,202$0.18M0.0%+21.1%0.039%Search for SEC Filing on Google Icon
12/26/2024JPMorgan Chase & Co.266,879$2.15M0.0%+2.9%0.543%Search for SEC Filing on Google Icon
11/27/2024Franklin Resources Inc.11,011$91K0.0%-13.6%0.022%Search for SEC Filing on Google Icon
11/19/2024Barclays PLC65,580$0.53M0.0%+279.9%0.133%Search for SEC Filing on Google Icon
11/15/2024Barclays PLC65,580$0.53M0.0%+279.9%0.134%Search for SEC Filing on Google Icon
11/15/2024Y Intercept Hong Kong Ltd31,194$0.25M0.0%N/A0.064%Search for SEC Filing on Google Icon
11/15/2024XTX Topco Ltd20,439$0.17M0.0%+34.5%0.042%Search for SEC Filing on Google Icon
11/15/2024Jane Street Group LLC144,575$1.17M0.0%+1.1%0.296%Search for SEC Filing on Google Icon
11/15/2024Wellington Management Group LLP191,329$1.54M0.0%-45.4%0.391%Search for SEC Filing on Google Icon
11/15/2024State Street Corp1,191,621$9.60M0.0%-6.0%2.436%Search for SEC Filing on Google Icon
11/15/2024Jacobs Levy Equity Management Inc.576,447$4.65M0.0%-1.7%1.178%Search for SEC Filing on Google Icon
11/14/2024PDT Partners LLC87,177$0.70M0.1%+31.2%0.178%Search for SEC Filing on Google Icon
11/14/2024Verition Fund Management LLC12,642$0.10M0.0%-63.2%0.026%Search for SEC Filing on Google Icon
11/14/2024Martingale Asset Management L P54,450$0.44M0.0%+14.4%0.111%Search for SEC Filing on Google Icon
11/14/2024UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC117,505$0.95M0.0%-15.4%0.240%Search for SEC Filing on Google Icon
11/14/2024Zurcher Kantonalbank Zurich Cantonalbank16,978$0.14M0.0%+29.1%0.035%Search for SEC Filing on Google Icon
11/13/2024BNP Paribas Financial Markets305,480$2.46M0.0%+88.9%0.624%Search for SEC Filing on Google Icon
11/13/2024Quantbot Technologies LP7,396$60K0.0%N/A0.015%Search for SEC Filing on Google Icon
11/13/2024The Manufacturers Life Insurance Company15,611$0.13M0.0%-6.1%0.032%Search for SEC Filing on Google Icon
11/12/2024Algert Global LLC105,609$0.85M0.0%N/A0.216%Search for SEC Filing on Google Icon
11/5/2024GSA Capital Partners LLP229,780$1.85M0.1%+12.6%0.470%Search for SEC Filing on Google Icon
10/25/2024China Universal Asset Management Co. Ltd.9,409$76K0.0%+64.7%0.019%Search for SEC Filing on Google Icon
10/23/2024Ballentine Partners LLC12,848$0.10M0.0%N/A0.026%Search for SEC Filing on Google Icon
10/3/2024SG Americas Securities LLC15,853$0.13M0.0%-90.2%0.032%Search for SEC Filing on Google Icon
9/16/2024Point72 Asia Singapore Pte. Ltd.9,057$77K0.0%-23.3%0.019%Search for SEC Filing on Google Icon
8/15/2024The Manufacturers Life Insurance Company16,623$0.14M0.0%-12.8%0.034%Search for SEC Filing on Google Icon
8/15/2024Point72 Asia Singapore Pte. Ltd.9,057$77K0.0%-23.3%0.019%Search for SEC Filing on Google Icon
8/14/2024Squarepoint Ops LLC116,256$0.99M0.0%N/A0.238%Search for SEC Filing on Google Icon
8/14/2024Marshall Wace LLP297,499$2.52M0.0%+83.6%0.608%Search for SEC Filing on Google Icon
8/14/2024Bank of Montreal Can160,138$1.41M0.0%+141.0%0.327%Search for SEC Filing on Google Icon
8/13/2024Baupost Group LLC MA4,200,021$35.62M1.0%-36.3%8.585%Search for SEC Filing on Google Icon
8/12/2024XTX Topco Ltd15,196$0.13M0.0%N/A0.031%Search for SEC Filing on Google Icon
8/12/2024Hsbc Holdings PLC12,829$0.11M0.0%N/A0.026%Search for SEC Filing on Google Icon
8/9/2024Dimensional Fund Advisors LP330,181$2.80M0.0%+38.4%0.679%Search for SEC Filing on Google Icon
8/8/2024American Century Companies Inc.57,611$0.49M0.0%+11.7%0.118%Search for SEC Filing on Google Icon
8/6/2024Los Angeles Capital Management LLC33,760$0.29M0.0%N/A0.069%Search for SEC Filing on Google Icon
8/1/2024Rhumbline Advisers77,084$0.65M0.0%-16.4%0.159%Search for SEC Filing on Google Icon
7/26/2024Bank of New York Mellon Corp150,972$1.28M0.0%-6.8%0.310%Search for SEC Filing on Google Icon
7/12/2024SG Americas Securities LLC162,388$1.38M0.0%-22.5%0.334%Search for SEC Filing on Google Icon
5/16/2024California State Teachers Retirement System38,454$0.35M0.0%-17.1%0.079%Search for SEC Filing on Google Icon
5/16/2024Jacobs Levy Equity Management Inc.557,971$5.01M0.0%+41.6%1.149%Search for SEC Filing on Google Icon
5/16/2024Kennedy Capital Management LLC38,202$0.34M0.0%+3.7%0.079%Search for SEC Filing on Google Icon
5/15/2024Price T Rowe Associates Inc. MD49,475$0.44M0.0%+7.7%0.102%Search for SEC Filing on Google Icon
5/14/2024Baupost Group LLC MA6,594,126$59.15M1.6%-11.1%13.579%Search for SEC Filing on Google Icon
5/14/2024American International Group Inc.23,942$0.22M0.0%-6.5%0.049%Search for SEC Filing on Google Icon
5/10/2024Vanguard Group Inc.2,685,853$24.09M0.0%-23.0%5.531%Search for SEC Filing on Google Icon
5/9/2024State Board of Administration of Florida Retirement System22,671$0.20M0.0%+28.2%0.047%Search for SEC Filing on Google Icon
5/8/2024Russell Investments Group Ltd.45,114$0.41M0.0%+55.7%0.093%Search for SEC Filing on Google Icon
5/7/2024Swiss National Bank73,742$0.66M0.0%-11.5%0.152%Search for SEC Filing on Google Icon
5/7/2024SG Americas Securities LLC209,566$1.88M0.0%+6.3%0.432%Search for SEC Filing on Google Icon
5/1/2024BNP Paribas Financial Markets33,458$0.30M0.0%+30.7%0.069%Search for SEC Filing on Google Icon
5/1/2024Mirae Asset Global Investments Co. Ltd.52,876$0.47M0.0%+16.6%0.109%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Theravance Biopharma logo
Theravance Biopharma, Inc. is a diversified biopharmaceutical company primarily focused on the discovery, development and commercialization of organ-selective medicines. Its purpose is to pioneer a new generation of small molecule drugs designed to better meet patient needs. Its research is focused in the areas of inflammation and immunology. In pursuit of its purpose, Theravance Biopharma applies insights and innovation at each stage of its business and utilizes its internal capabilities and those of partners around the world. The Company applies organ-selective expertise to target disease biologically, to discover and develop medicines that may expand the therapeutic index with the goal of maximizing efficacy and limiting systemic side effects. These efforts leverage years of experience in developing lung-selective medicines to treat respiratory disease, including FDA-approved YUPELRI® (revefenacin) inhalation solution indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD). Its pipeline of internally discovered programs is targeted to address significant patient needs. Theravance Biopharma has an economic interest in potential future payments from Glaxo Group Limited or one of its affiliates (GSK) pursuant to its agreements with Innoviva, Inc. relating to certain programs, including TRELEGY. For more information, please visit www.theravance.com.
Read More on Theravance Biopharma

Today's Range

Now: $9.21
Low: $9.21
High: $9.50

50 Day Range

MA: $9.30
Low: $8.44
High: $10.47

52 Week Range

Now: $9.21
Low: $7.44
High: $10.90

Volume

179,728 shs

Average Volume

293,625 shs

Market Capitalization

$455.63 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.15

Who are the company insiders with the largest holdings of Theravance Biopharma?

Theravance Biopharma's top insider shareholders include:
  1. Eli Samaha (Major Shareholder)
  2. Richard A Graham (SVP)
  3. Rhonda Farnum (SVP)
Learn More about top insider investors at Theravance Biopharma.

Who are the major institutional investors of Theravance Biopharma?

Theravance Biopharma's top institutional shareholders include:
  1. Newtyn Management LLC — 9.68%
  2. Vanguard Group Inc. — 4.09%
  3. Park West Asset Management LLC — 3.65%
  4. Geode Capital Management LLC — 1.75%
  5. D. E. Shaw & Co. Inc. — 1.70%
  6. Dimensional Fund Advisors LP — 1.13%
Learn More about top institutional investors of Theravance Biopharma stock.

Which major investors are selling Theravance Biopharma stock?

During the last quarter, TBPH stock was sold by these institutional investors:
  1. Jacobs Levy Equity Management Inc.
  2. Jane Street Group LLC
  3. Marshall Wace LLP
  4. Park West Asset Management LLC
  5. Squarepoint Ops LLC
  6. PDT Partners LLC
  7. JPMorgan Chase & Co.
  8. Vanguard Group Inc.

Which major investors are buying Theravance Biopharma stock?

In the previous quarter, TBPH stock was acquired by institutional investors including:
  1. Newtyn Management LLC
  2. Dimensional Fund Advisors LP
  3. Millennium Management LLC
  4. D. E. Shaw & Co. Inc.
  5. Trexquant Investment LP
  6. Nuveen Asset Management LLC
  7. Public Employees Retirement System of Ohio
  8. Corton Capital Inc.